Home
About
data set
Resources
news & events
PHARMA FUNDING
Contact

News

Satisfied customers lorem ipsum dolor sit amet, consur adipiscing elit, sed do eiusmod tempor.

February 2025 - InRAD receives funding from Bristol Myers Squibb
News

February 2025 - InRAD receives funding from Bristol Myers Squibb

Read more
IconIcon
September 2024 - InRAD receives funding from Novo Nordisk and Eli Lilly
News

September 2024 - InRAD receives funding from Novo Nordisk and Eli Lilly

Read more
IconIcon

Subscribe to our newsletter

For general enquiries, please email us at info@InRADnetwork.org
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

International Registry for Alzheimer's Disease and Other Dementias

*We are grateful for the work of the Steering Committee who shaped the questionnaire, based on the work of Ellison et al. Outcome measures for Alzheimer's disease: A global inter-societal Delphi consensus. Alzheimers Dement. 2023 Jun;19(6):2707-2729, and for the early discussions with other important stakeholders who have been so collaborative and constructive. Our privacy policy is available on request. If you have any queries, questions or comments about our privacy policy, you can contact us at any time by emailing info@InRADnetwork.org - we aim to respond within 7 business days. Stichting International Registry for Alzheimer’s Disease and Other Dementias Foundation, incorporated in the Netherlands: info@inradnetwork.org

Pages
Home 1
Home 2
Home 3
Team 1
Team 2
Team 3
About
Pages
Home
About
Data Set
Resources
News & Events
Pharma Funding
Contact
HELP
Retention Schedule
Privacy Notice
Cookie Policy
Gender equality plan

Design by Autonomous Health